Fluxion Biosciences announced today a foundational patent has been issued for its ERASE-Seq technology, US patent 10,294,518, ‘Methods and Systems for Ultra-sensitive Detection of Genomic Alterations’. The ERASE-Seq technology and testing approach leverage inter-sample statistical analysis, rather than tracking of ...
Read More »Fluxion Biosciences Launches Spotlight 59 NGS Oncology Panel For Liquid Biopsies
The Spotlight 59™ panel and novel ERASE-Seq methodology are designed for ultra-sensitive variant detection from CTCs and cfDNA Fluxion Biosciences, Inc. announced the launch of the Spotlight 59 Oncology Panel. Designed for the detection of mutations from liquid biopsy samples, ...
Read More »